Newborn Tablet 50 Units (Calidino Genase)

Adult dose

Administer 30~150I.U. per day orally in 3 divided doses. The dose may be adjusted according to age and symptoms.

This medication should not be used in patients with bleeding, such as immediately after cerebral hemorrhage. Additionally, since this medication contains lactose, patients with genetic issues that prevent lactose digestion, such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption, should not take it. Rarely, hypersensitivity reactions such as skin rashes or itching may occur while taking this medication, and you should stop taking it immediately if these symptoms appear. Rapid heart rate symptoms may occasionally occur, so caution is advised. It may affect the digestive system, leading to symptoms such as stomach discomfort, nausea, vomiting, loss of appetite, upper abdominal pain, diarrhea, or constipation. Additionally, symptoms such as a feeling of heat, headache, a feeling of heaviness in the head, drowsiness, or fatigue may rarely occur. In elderly patients, due to decreased bodily function, special caution such as dose reduction is needed when using this medication.

• rash
• itching
• palpitations
• discomfort in the stomach
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius (room temperature). Proper storage ensures the medication's effectiveness and safety.

Appearance

White round enteric-coated film tablet

Package unit

Domestic use - 30 tablets/bottle, Domestic use - 300 tablets/bottle, Domestic use - 500 tablets/bottle, Export use - 100 tablets/box [10 tablets/PTPX10]